The Issues Around Opioid Prescribing in HIV-Related Pain

• Hogg A , LimaV, SterneJ et al.; Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet372(9635) , 293–299 (2008).
   PubMed Web of Science ®Google Scholar
• Rietschel P , CorcoranC, StanleyT et al. Prevalence of hypogonadism among men with weight loss related to human immunodeficiency virus infection who were receiving highly active antiretroviral therapy. Clin. Infect. Dis. 31(5) , 1240–1244 (2000).
   PubMed Web of Science ®Google Scholar
• Steele A , HendersonE, RogersT. Mu-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication. Virology309 , 99–107 (2003).
   PubMed Web of Science ®Google Scholar
• Bruce R , AlticeF, GourevitchM, FriedlandG. Pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications: implications and management for clinical practice. J. AIDS41(5) , 563–572 (2006).
   PubMed Web of Science ®Google Scholar
• Chou R , FanciulloG, FineP et al.; American Pain Society – American Academy of Pain Medicine Opioids Guidelines Panel. Opioid treatment guidelines: Clinical Guidelines for the use of chronic opioid therapy in chronic noncancer pain. J. Pain10(2) , 113–130 (2009).
   PubMed Web of Science ®Google Scholar
• Merlin J , CenL, PraestqaardA et al. Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era. J. Pain Symptom Manage. 43(3) , 638–645 (2012).
   PubMed Web of Science ®Google Scholar
• Dobalian A , TsaoJ, DuncanR. Pain and the use of outpatient services among persons with HIV: results from a nationally representative survey medical care. Med. Care42(2) , 129–138 (2004).
   PubMed Web of Science ®Google Scholar
• Newshan G , BennettJ, HolmanS. Pain and other symptoms in ambulatory HIV patients in the age of highly active antiretroviral therapy. J. Assoc. Nurses AIDS Care13(4) , 78–83 (2002).
   PubMedGoogle Scholar
• Lorenz K , ShapiroM, AschS et al. Associations of symptoms and health-related quality of life: findings from a national study of persons with HIV infection. Ann. Intern. Med. 134 , 854–860 (2001).
   PubMed Web of Science ®Google Scholar
• Tsao J , DobalianA, SteinJ. Illness burden mediates the relationship between pain and illicit drug use in persons living with HIV. Pain119 , 124–132 (2005).
   PubMed Web of Science ®Google Scholar
• Sullivan A , CurtisH, SabinC, JohnsonM. Newly diagnosed HIV infections: review in UK and Ireland. BMJ330 , 1301–1302 (2005).
   PubMed Web of Science ®Google Scholar
• Adler A , Mounier-JackS, CokerRJ. Late diagnosis of HIV in Europe: definitional and public health challenges. AIDS Care21 , 284–293 (2009).
   PubMed Web of Science ®Google Scholar
• Brechtl J , BreitbartW, GaliettaM. The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J. Pain Symp. Manage.21(1) , 41–51 (2001).
   PubMed Web of Science ®Google Scholar
• Rosenblum A , JosephH, FongC, KipnisS, ClelandC, PortenoyR. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA289 , 2370–2378 (2003).
   PubMed Web of Science ®Google Scholar
• Harding R , SelmanL, AgupioG et al. Prevalence, burden and correlates of physical and psychological symptoms among HIV palliative care patients in sub-Saharan Africa: an international multicentre study. J. Pain Symptom Manage. 44(1) , 1–9 (2012).
   PubMed Web of Science ®Google Scholar
• Hewitt D , McDonaldM, PortenoyR et al. Pain syndromes and etiologies in ambulatory AIDS patients. Pain 70 , 117–123 (1997).
   PubMed Web of Science ®Google Scholar
• Keswani S , PardoC, CherryC et al. HIV-associated sensory neuropathies. AIDS 16 , 2105–2117 (2002).
   PubMed Web of Science ®Google Scholar
• So Y , HoltzmanD, AbramsD, OlneyR. Peripheral neuropathy associated with acquired immunodeficiency syndrome – prevalence and clinical features from a population based survey. Arch. Neurol.45 , 945–948 (1988).
   PubMed Web of Science ®Google Scholar
• Cherry C , WadleyA, KamermanP. Painful HIV-associated sensory neuropathy. Pain Manage.2(6) , 543–552 (2012).
   PubMedGoogle Scholar
• Evans S , EllisR, ChenH et al. Peripheral neuropathy in HIV. AIDS 25(7) , 919–928 (2011).
   PubMed Web of Science ®Google Scholar
• Ellis R , RosarioD, CliffordD et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER study. Arch. Neurol. 67(5) , 552–558 (2010).
   PubMedGoogle Scholar
• Wadley A , CherryC, PriceP, KamermanP. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J. Pain Symptom Manage.41(4) , 700–706 (2010).
   PubMed Web of Science ®Google Scholar
• Edelman J , GordonK, BeckerW et al. Receipt of opioid analgesics by HIV-infected and uninfected patients. J. Gen. Int. Med. 28(1) , 82–90 (2013).
   PubMed Web of Science ®Google Scholar
• Silverberg M , RayG, SaundersK et al. Prescription long-term opioid use in HIV-infected patients. Clin. J. Pain 28(1) , 39–46 (2012).
   PubMed Web of Science ®Google Scholar
• Onen N , BarretteEP, ShachamE, TaniguchiT, DonovanM and Overton E. A review of opioid prescribing practices and associations with repeat opioid prescriptions in a contemporary outpatient HIV clinic. Pain Practice12(6) , 440–448 (2012).
   PubMed Web of Science ®Google Scholar
• Manchikanti L , AbdiS, AtluriS et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 1 – evidence assessment. Pain Phys. 15 , S1–S66 (2012).
   PubMed Web of Science ®Google Scholar
• Kaplan R , SlywkaJ, SlagleS, RiesK. Titrated morphine analgesic regimen comparing substance users and non-users with AIDS-related pain. J. Pain Symptom Manage.19(4) , 265–273 (2000).
   PubMed Web of Science ®Google Scholar
• Newshan G , LefkowitzM. Transdermal fentanyl for chronic pain in AIDS: a pilot study. J. Pain Symptom Manage.21 , 69–77 (2001).
   PubMed Web of Science ®Google Scholar
• Newshan G , StaatsJ. Evidence-based pain guidelines in HIV care. J. Assoc. Nurses AIDS Care24(1 Suppl.) , S112–S126 (2013).
   Google Scholar
• Koeppe J , LichtensteinK, ArmonC et al. Factors associated with initiation of prolonged analgesic use among patients in the HIV outpatient study (HOPS). Clin. J. Pain 27(8) , 699–706 (2011).
   PubMed Web of Science ®Google Scholar
• Phillips T , CherryC, CoxS, MarshallS, RiceA. Pharmacological treatment of painful HIV-associated sensory neuropathy: a systematic review and meta-analysis of randomised controlled trials. PLoS ONE5(12) , e14433 (2010).
   PubMed Web of Science ®Google Scholar
• Furlan A , SandovalJ, Mailis-GagnonA, TunksE. Opioids for chronic non-cancer pain: a meta-analysis of effectiveness and side effects. CMAJ174(11) , 1589–1594 (2006).
   PubMed Web of Science ®Google Scholar
• Lee M , SilvermanS, HansenH, PatelV, ManchikantiL. A comprehensive review of opioid-induced hyperalgesia. Pain Phys.14 , 145–161 (2011).
   PubMed Web of Science ®Google Scholar
• Office of Applied Studies, Substance Abuse and Mental Health Service Administration. Results from the 2004 National Survey on Drug Use and Health. Department of Health and Human Services, MD, USA (2005).
   Google Scholar
• Dunn K , SaundersK, RutterC et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann. Intern. Med. 152 , 85–92 (2010).
   PubMed Web of Science ®Google Scholar
• Singh H , PurohitV, AhluwaliaB. Methadone blocks dopamine-mediated release of gonadotropins in rat hypothalamus. Neuroendocrinology34(5) , 347–352 (1982).
   PubMed Web of Science ®Google Scholar
• Rhodin A , StridsbergM, GordhT. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long term oral opioid treatment. Clin. J. Pain26(5) , 374–380 (2010).
   PubMed Web of Science ®Google Scholar
• McCarthy L , WetzelM, SlikerJ, EisensteinT, RogersT. Opioids, opioid receptors, and the immune response. Drug Alcohol Depend.62(2) , 111–123 (2001).
   PubMed Web of Science ®Google Scholar
• Wybran J , AppelboomT, FamaeyJ, GovaertsA. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J. Immunol.123 , 1068–1070 (1979).
   PubMed Web of Science ®Google Scholar
• Margolick J , MunozA, VlahovD et al. Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection. JAMA 267 , 1631–1636 (1992).
   PubMed Web of Science ®Google Scholar
• Finley M , HappelC, KaminskeyD, RogersT. Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression. Cell. Immunol.252 , 146–154 (2008).
   PubMed Web of Science ®Google Scholar
• McCance-Katz E , MoodyD, MorseG et al. Interaction between buprenorphine and atazanavir or atazanavir/ritonavir. Drug Alcohol Depend. 91(2–3) , 269–278 (2007).
   PubMed Web of Science ®Google Scholar
• Otero M , FuertesA, SanchezR et al. Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert. AIDS 13(8) , 1004–1005 (1999).
   PubMed Web of Science ®Google Scholar
• Stocker H , KruseG, KreckelP et al. Nevirapine significantly reduces the levels of racemic methadone and (R)-methadone in human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother. 48 , 4148–4153 (2004).
   PubMed Web of Science ®Google Scholar
• Clarke S , MulcahyF, TjiaJ et al. The pharmacokinetics of methadone in HIV-positive patients receiving the non-nucleoside reverse transcriptase inhibitor efavirenz. Br. J. Clin. Pharmacol. 51 , 213–217 (2001).
   PubMed Web of Science ®Google Scholar
• Tashima K , BoseT, GormleyJ et al. The potential impact of efavirenz on methadone maintenance. Presented at: 9th European Congress of Clinical Microbiology and Infectious Diseases. Berlin, Germany, 21–24 March 1999 (Abstract P0552).
   Google Scholar
• Beauverie P , TaburetAM, DessallesMC et al. Therapeutic drug monitoring of methadone in HIV-infected patients receiving protease inhibitors. AIDS 12 , 2510–2511 (1998).
   PubMed Web of Science ®Google Scholar
• McCance-Katz EF , RaineyP, FriedlandG, JatlowP. The protease inhibitor lopinavir/ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin. Infect. Dis.37 , 476–482 (2003).
   PubMed Web of Science ®Google Scholar
• Lüthi B , HuttnerA, SpeckRF, MuellerNJ. Methadone-induced torsade de pointes after stopping lopinavir-ritonavir. Eur. J. Clin. Microbiol. Infect. Dis.26(5) , 367–379 (2007).
   PubMed Web of Science ®Google Scholar
• McCance-Katz EF , SullivanLS, NallaniS. Drug interactions of clinical importance between the opioids, methadone and buprenorphine, and frequently prescribed medications: a review. Am. J. Addictions19(1) , 4–16 (2010).
   PubMed Web of Science ®Google Scholar
• Olkkola K , PalkamaV, NeuvonenP. Ritonavir‘s role in reducing fentanyl clearance and prolonging its half-life. Anesthesiology91(3) , 681–685 (1999).
   PubMed Web of Science ®Google Scholar
• Nieminen T , HagelbergN, SaariT et al. Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir. Eur. J. Clin. Pharmacol. 66(10) , 977–985 (2010).
   PubMed Web of Science ®Google Scholar
• Fishbain D , ColeB, LewisJ, RosomoffH, RosomoffR. What percentage of chronic non-malignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med.9(4) , 444–459 (2008).
   PubMed Web of Science ®Google Scholar
• Sullivan M , EdlundM, FanMY, DevriesA, Brennen Braden J, Martin B. Risk for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP study. Pain15 , 332–339 (2010).
   Google Scholar
• Passik S , HaysL, EisnerN, KirschK. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J. Pain Palliat. Care Pharmacother.20(2) , 5–13 (2006).
   PubMedGoogle Scholar
• Barry D , GouletJ, KernsR et al. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain 152 , 1133–1138 (2011).
   PubMed Web of Science ®Google Scholar
• Hansen L , PenkoJ, GuzmanD Bangsberg D, Miaskowski C, Kushel M. Aberrant behaviours with prescription opioids and problem drug use history in a community-based cohort of HIV-infected individuals. J. Pain Symptom Manage.42(6) , 893–902 (2011).
   PubMed Web of Science ®Google Scholar
• Robinson-Papp J , ElliottK, SimpsonD, MorgelloS. Problematic prescription opioid use in an HIV-infected cohort; the importance of universal toxicology testing. J. Acquir. Immune Defic. Syndr.61(2) , 187–193 (2012).
   PubMed Web of Science ®Google Scholar
• Tsao J , SteinJ, DobalianA. Pain, problem drug use history, and aberrant analgesic use behaviors in persons living with HIV. Pain133 , 128–137 (2007).
   PubMed Web of Science ®Google Scholar
• Kirsh K , WhitcombL, DonaghyK, PassikS. Abuse and addiction issues in medically ill patients with pain: Attempts at clarification of terms and empirical study. Clin. J. Pain18(Suppl. 4) , S52–S60 (2002).
   PubMed Web of Science ®Google Scholar
• Larue F , FontaineA, ColleauS. Underestimation and undertreatment of pain in HIV disease: multicentre study. Br. Med. J.314 , 23–28 (1997).
   PubMed Web of Science ®Google Scholar
• Breitbart W , RosenfeldB, PassikS, KaimM, Funesti-EschJ, SteinK. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain72 , 235–243 (1997).
   PubMed Web of Science ®Google Scholar
• Chander G , HimelhochS, MooreR. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs66(6) , 769–789 (2006).
   PubMed Web of Science ®Google Scholar
• Merlin J , WestfallA, RaperJ et al. Pain, mood and substance abuse in HIV: implications for clinic visit utilization, antiretroviral therapy adherence, and virologic failure. J. Acquir. Immune Defic. Syndr. 61(2) , 164–170 (2012).
   PubMed Web of Science ®Google Scholar
• Passik S , KirshK, McDonaldM et al. A pilot survey of aberrant drug-taking attitudes and behaviors in samples of cancer and AIDS patients. J. Pain Symptom Manage. 19(4) , 274–286 (2000).
   PubMed Web of Science ®Google Scholar
• Lum P , LittleS, BotskoM et al. Opioid-prescribing practices and provider confidence recognizing opioid analgesic abuse in HIV primary settings. J. Acquir. Immune Defic. Syndr. 56(Suppl. 1) , S91–S97 (2011).
   PubMed Web of Science ®Google Scholar
• Vijayaraghavan M , PenkoJ, GuzmanD, MiaskowskiC, KushelMB. Primary care providers‘ judgments of opioid analgesic misuse in a community based cohort of HIV-infected indigent adults. J. Gen. Intern. Med.25(4) , 412–418 (2011).
   Google Scholar

▪ Websites

• Health Protection Agency. HIV in the UK: 2012 report. www.hpa.org.uk/webc/hpawebfile/hpaweb_c/1317137200016 (Accessed 24Febuary2013)
   Google Scholar
• The British Pain Society. Opioids for persistent pain: good practice (2010). www.britishpainsociety.org/book_opioid_main.pdf (Accessed 24Febuary2013)
   Google Scholar
• The University of Liverpool. HIV drug interactions. www.hiv-druginteractions.org (Accessed 24Febuary2013)
   Google Scholar
• The National Survey on Drug Use and Health report: HIV/AIDS and substance use (2010). www.samhsa.gov/data/2k10/HIV-AIDS/HIV-AIDs.htm (Accessed 24Febuary2012)
   Google Scholar